Delivery Order SPE2DB22D3501-SPE2DB25FWW69
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,441.05 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packages of 30 units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 14, 2025, issued on August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the contract at its corporate office location. The delivery order is a child contract...
- The Defense Logistics Agency has awarded a delivery order valued at $5,168.73 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 11, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a delivery order valued at $2,574.00 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count units). This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 23, 2025, and represents a non-set-aside procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,247.04 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets (30-unit dose packages) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count) with a ceiling value of $3,474.96. This competitively awarded, non-set-aside contract has a firm fixed price structure and an ultimate completion date of August 18, 2025. The delivery order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,255.69 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price contract was executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30s, with a ceiling value of $1,140.26. This is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements. The contract utilizes no set-aside designation and was competitively awarded through the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,617.96 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This firm fixed-price, non-set-aside contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,287.00 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablet unit dose packs (30 count) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price contract was awarded on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,176.82 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is scheduled for ultimate completion on July 29, 2025, with performance to be completed at the vendor's facility in...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWW69Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging of 30 units. The contract, valued at $1,087.70, was competitively awarded without set-aside designation and carries a firm fixed price structure. The award date was August 14, 2025, with an ultimate completion date of August 15, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, which also serves as the company's corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime indefinite delivery vehicle authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems, and this award reflects the company's capability to fulfill specific pharmaceutical requirements through open competition within its broader federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/14/25 |